Takeshi Terui

615 total citations
18 papers, 517 citations indexed

About

Takeshi Terui is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Takeshi Terui has authored 18 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Hematology and 4 papers in Genetics. Recurrent topics in Takeshi Terui's work include Chronic Myeloid Leukemia Treatments (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers) and Acute Myeloid Leukemia Research (2 papers). Takeshi Terui is often cited by papers focused on Chronic Myeloid Leukemia Treatments (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers) and Acute Myeloid Leukemia Research (2 papers). Takeshi Terui collaborates with scholars based in Japan, United States and Russia. Takeshi Terui's co-authors include Paul A. Randazzo, Richard Kahn, Rishu Takimoto, Yoshiro Niitsu, Junji Kato, Takuya Matsunaga, Anthony G. Ferrige, Henry M. Fales, Tetsuji Takayama and Masayoshi Kobune and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Cell Biology and Blood.

In The Last Decade

Takeshi Terui

18 papers receiving 506 citations

Peers

Takeshi Terui

ONCOL

HEMAT

Jon Terrett United Kingdom

Ted Duffy United States

Jörg Moelleken Germany

Mikael Herlevsen United States

Tetsuya Otsuki Japan

Shunsuke Kon Japan

Chantal Melchior Luxembourg

Christa L. Brown United States

Vaidehi Krishnan Singapore

J. Simon Anderson United Kingdom

Jon Terrett United Kingdom

Takeshi Terui

331 ×0.8

236 ×1.5

94 ×1.0

ONCOL

47 ×1.0

41 ×0.9

HEMAT

Citations per year, relative to Takeshi Terui Takeshi Terui (= 1×) peers Jon Terrett

Countries citing papers authored by Takeshi Terui

Since Specialization

Citations

This map shows the geographic impact of Takeshi Terui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeshi Terui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeshi Terui more than expected).

Fields of papers citing papers by Takeshi Terui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeshi Terui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeshi Terui. The network helps show where Takeshi Terui may publish in the future.

Co-authorship network of co-authors of Takeshi Terui

This figure shows the co-authorship network connecting the top 25 collaborators of Takeshi Terui. A scholar is included among the top collaborators of Takeshi Terui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeshi Terui. Takeshi Terui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Kuribayashi, Kageaki, Kiminori Nakamura, Maki Tanaka, et al.. (2007). Essential role of protein kinase C ζ in transducing a motility signal induced by superoxide and a chemotactic peptide, fMLP. The Journal of Cell Biology. 176(7). 1049–1060. 22 indexed citations

Araki, Naoko, Rishu Takimoto, Akihito Fujimi, et al.. (2007). [Reappearance of t(12;17)-positive primary myelofibrosis following Ph+ CML cell reduction by imatinib].. PubMed. 48(6). 518–23. 1 indexed citations

Takimoto, Rishu, Junji Kato, Takeshi Terui, et al.. (2005). Augmentation of antitumor effects of p53 Gene therapy by combination with HDAC inhibitor. Cancer Biology & Therapy. 4(4). 427–434. 54 indexed citations

Kuribayashi, Kageaki, Takuya Matsunaga, Toshio Sakai, et al.. (2005). A Patient with TP53 Germline Mutation Developed Bowen's Disease and Myelodysplastic Syndrome with Myelofibrosis after Chemotherapy against Ovarian Cancer. Internal Medicine. 44(5). 490–495. 7 indexed citations

Murase, Kazuyuki, Takuya Matsunaga, Naoko Takeuchi, et al.. (2004). [Second hematologic response and disappearance of the ABL gene mutant clone by cessation of imatinib in a CML patient with resistance to imatinib].. PubMed. 45(9). 1028–32. 1 indexed citations

Kobune, Masayoshi, Yoshinori Ito, Yutaka Kawano, et al.. (2004). Indian hedgehog gene transfer augments hematopoietic support of human stromal cells including NOD/SCID–ß2m–/– repopulating cells.. Blood. 104(4). 1002–1009. 45 indexed citations

Matsunaga, Takuya, Kazuyuki Murase, Hiroyuki Kuroda, et al.. (2004). [Successful induction and complete improvement of myelofibrosis and erythema nosodum with cladribine in a case of hairy cell leukemia].. PubMed. 31(6). 965–9. 1 indexed citations

Kuroda, Hiroyuki, Takuya Matsunaga, Takeshi Terui, et al.. (2003). Decrease of Smad4 gene expression in patients with essential thrombocythaemia may cause an escape from suppression of megakaryopoiesis by transforming growth factor‐β1. British Journal of Haematology. 124(2). 211–220. 14 indexed citations

Hisai, Hiroyuki, Junji Kato, Masayoshi Kobune, et al.. (2003). Increased expression of angiogenin in hepatocellular carcinoma in correlation with tumor vascularity.. PubMed. 9(13). 4852–9. 71 indexed citations

10.

Nakamura, Kiminori, Hirofumi Hamada, Katsunori Sasaki, et al.. (2003). Inhibition of type I procollagen production by tRNA^Val CTE‐HSP47 ribozyme. The Journal of Gene Medicine. 5(9). 784–794. 9 indexed citations

11.

Terui, Takeshi, Ken Murakami, Rishu Takimoto, et al.. (2003). Induction of PIG3 and NOXA through acetylation of p53 at 320 and 373 lysine residues as a mechanism for apoptotic cell death by histone deacetylase inhibitors.. PubMed. 63(24). 8948–54. 96 indexed citations

12.

Fujimi, Akihito, Takuya Matsunaga, Katsuhisa Kogawa, et al.. (2002). A patient with paroxysmal nocturnal haemoglobinuria in whom granulocyte colony‐stimulating factor administration resulted in improvement of recurrent enterocolitis and its associated haemolytic attacks. British Journal of Haematology. 119(3). 858–862. 1 indexed citations

13.

Fujimi, Akihito, Takuya Matsunaga, Naofumi Takemoto, et al.. (2002). [Successful treatment with G-CSF and corticosteroid of adult idiopathic autoimmune neutropenia presenting as recurrent enterocolitis].. PubMed. 43(11). 998–1003. 1 indexed citations

14.

Takahari, Daisuke, Takuya Matsunaga, Akihito Fujimi, et al.. (2002). [Treatment of chronic myelogenous leukemia with imatinib mesylate resulting in hematological remission and marked regression of myelofibrosis].. PubMed. 43(10). 924–30. 1 indexed citations

15.

Kahn, Richard, Takeshi Terui, & Paul A. Randazzo. (1996). Effects of acid phospholipids on ARF activities: Potential roles in membrane traffic. PubMed. 14(1-3). 209–214. 10 indexed citations

16.

Randazzo, Paul A., et al.. (1995). The Myristoylated Amino Terminus of ADP-ribosylation Factor 1 Is a Phospholipid- and GTP-sensitive Switch. Journal of Biological Chemistry. 270(24). 14809–14815. 108 indexed citations

17.

Kahn, Richard, Tim Stearns, Chunjiang Zhang, et al.. (1995). Mutational Analysis of Saccharomyces cerevisiae ARF1. Journal of Biological Chemistry. 270(1). 143–150. 74 indexed citations

18.

Niitsu, Yoshiro, et al.. (1987). Cloning and Expression of the Gene for Human Transforming Growth Factor-β in Escherichia Coli. Medical Entomology and Zoology. 41–55. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact